Rankings / Sleep & Recovery

Curcumin (turmeric)

Sleep & Recovery · Polyphenol

Tier C+

Reviewed by Read Off Label · Last reviewed · How we grade

polyphenolantioxidantcox-pathwayhepatotoxicity-flagnafldotc
5.5 / 10
Tier C+
Ev 6 Bn 5 Sf 5

Bottom line

Read Off Label grades Curcumin (turmeric) as C+ (5.5/10) based on moderate evidence, med benefit magnitude, and a med-risk safety profile.

Native curcumin absorption <1% — rapidly conjugated to glucuronide/sulfate and excreted.

Typical use: 500-2000 mg/day standardized curcuminoids; formulation matters — native (<1% absorption); piperine 5-20 mg co-admin… — OTC.

What this is

Native curcumin absorption <1% — rapidly conjugated to glucuronide/sulfate and excreted. **The formulation paradox is the central biohacker decision input**: bioavailability-enhanced forms (Meriva/phytosome; Theracurmin; BCM-95; NovaSol; piperine-boosted) deliver 5-30x higher plasma curcumin, but hepatotoxicity case reports are CONCENTRATED in exactly these formulations. EFSA, Italian Phytovigilance, DILIN, and Icelandic case clusters all point the same direction — bioavailability-enhanced products at standard supplement doses produce occasional idiosyncratic cholestatic hepatitis. EFSA's 180 mg/day ADI is below typical biohacker dosing. Italian Ministry of Health required new warning labels on Curcuma longa supplements 2024-2025. **OA paradox**: 2025 network MA on knee OA (17 studies) found conventional curcuminoid preparations had numerically LARGER WOMAC pain reduction (-3.17) than bioavailability-enhanced ones (-2.47) — complicates the "phytosomal is better" supplement-industry narrative. NAFLD/MASLD is the strongest specific indication for phytosomal curcumin per the 2025 ALT/AST pooled MA. **Practical read of 2024-2025 evidence**: (a) prefer conventional curcuminoids at moderate doses with food/fat; (b) stay below the EFSA ADI of ~3 mg/kg/day; (c) monitor LFTs if using bioavailability-enhanced forms long-term; (d) hold immediately if jaundice/dark urine/RUQ pain. Phytosomal/Meriva remains reasonable for NAFLD-targeted use under monitoring; for general anti-inflammatory or OA use, conventional is now better-justified.

Mechanism

Diferuloylmethane polyphenol from Curcuma longa; pleiotropic effects — NF-κB; COX-2; 5-LOX; JAK-STAT; Nrf2 inhibition/activation across dozens of pathways; native curcumin has <1% oral bioavailability and is rapidly conjugated/excreted; formulation strategies (phytosome, micelle, nanoemulsion, piperine co-administration) raise plasma exposure 5-30x

Dose & route

500-2000 mg/day standardized curcuminoids; formulation matters — native (<1% absorption); piperine 5-20 mg co-admin (~20x); phytosome/Meriva (~20-29x AUC); BCM-95 (~7x); Theracurmin (~27x AUC and ~5.6x Cmax vs Meriva); NovaSol micelle (very high Cmax with rapid decline)

Citations

Links go to the source. If a link is dead or you want something re-checked, let me know.

Common questions

Does Curcumin (turmeric) work?
Read Off Label rates the evidence for Curcumin (turmeric) as Moderate and the benefit magnitude as med, producing an overall grade of C+ (5.5/10). Native curcumin absorption <1% — rapidly conjugated to glucuronide/sulfate and excreted.
Is Curcumin (turmeric) safe?
Curcumin (turmeric) has a med risk profile in published human data. Legal status: OTC (EFSA ADI 180 mg curcumin/day for 60 kg adult ≈ 3 mg/kg/day; Italian Ministry of Health required new hepatotoxicity warning labels 2024-2025). This is not medical advice — see the disclaimer.
What is the typical dose for Curcumin (turmeric)?
500-2000 mg/day standardized curcuminoids; formulation matters — native (<1% absorption); piperine 5-20 mg co-admin (~20x); phytosome/Meriva (~20-29x AUC); BCM-95 (~7x); Theracurmin (~27x AUC and ~5.6x Cmax vs Meriva); NovaSol micelle (very high Cmax with rapid decline)
How does Curcumin (turmeric) work?
Diferuloylmethane polyphenol from Curcuma longa; pleiotropic effects — NF-κB; COX-2; 5-LOX; JAK-STAT; Nrf2 inhibition/activation across dozens of pathways; native curcumin has <1% oral bioavailability and is rapidly conjugated/excreted; formulation strategies (phytosome, micelle, nanoemulsion, piperine co-administration) raise plasma exposure 5-30x

This is an independent synthesis of published research by a non-clinician. Scores are opinions supported by citations, not prescriptions. See the full disclaimer and methodology for how this score was produced and what it does and doesn't mean.